SBSarah Ballou

Sarah Ballou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sarah Ballou has a total of 208 co-authors. Here are the top co-authors by number of shared publications:

  • Anthony Lembo

    Department of Gastroenterology, Hepatology and Nutrition, Digestive Disease Institute, Cleveland Clinic, Cleveland, Ohio, USA

    19 shared publications
  • Johanna Iturrino

    Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America

    16 shared publications
  • Vikram Rangan

    Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, Massachusetts

    15 shared publications
  • Judy Nee

    Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA

    14 shared publications
  • Prashant Singh

    Division of Gastroenterology, Department of Medicine University of Michigan Medical Center Ann Arbor Michigan USA

    14 shared publications
  • Judy Nee

    Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center Harvard Medical School Boston Massachusetts USA

    13 shared publications

Latest Publications

  • Abelchia: A Clinical Review of Retrograde Cricopharyngeus Dysfunction and Inability to Belch for Gastroenterologists

    by Chethan Ramprasad, C. Prakash Gyawali, Baha Moshiree, Adrianna Wierzbicka, Ofer Fass, Anthony Lembo, Vikram Rangan, Sarah Ballou, Trisha Pasricha, Stephanie E. Teng, et al.

    Abelchia, also termed the inability to belch syndrome, is an increasingly recognized upper esophageal sphincter (UES) disorder characterized by retrograde cricopharyngeal dysfunction (RCPD). This disorder is highly relevant to gastroenterologists since presentation consists of common upper gastrointestinal symptoms including chest pain, gurgling noises in the chest, abdominal pressure, and bloating, often misattributed to alternate foregut disorders. Abelchia is thought to result from absent or incomplete UES relaxation in response to retrograde esophageal air distension, causing esophageal air trapping, despite preserved anterograde swallowing-related UES relaxation. The diagnosis is suspected based on clinical presentation and absence of alternate esophageal structural/motor disorders and supported by high-resolution impedance manometry with carbonated beverage challenge. Injection of botulinum toxin into the UES during rigid esophagoscopy is the mainstay of treatment, though data supporting this are largely derived from case series. Symptom benefit typically outlasts the general duration of efficacy of botulinum toxin, suggesting retraining of retrograde UES relaxation and the ability to belch. Consequently, behavioral therapy has been also reported to be of benefit. Randomized trials, standardized diagnostic criteria, and long-term outcome studies are lacking. This review summarizes the evolving literature on abelchia with emphasis on clinical presentation, diagnostic evaluation, differential diagnosis, treatment, and the role of gastroenterologists in identifying this underrecognized disorder.

  • Irritable bowel syndrome

    by Lin Chang, Maura Corsetti, William D. Chey, Alexander C. Ford, Max J. Schmulson, Andrea Shin, Giovanni Barbara, Sarah Ballou, Emeran A. Mayer, Kewin T. Siah, et al.

    Irritable bowel syndrome (IBS) is one of the most prevalent disorders of gut–brain interaction, characterized by recurrent abdominal pain or abdominal discomfort associated with altered bowel habits in the absence of identifiable structural disease. IBS affects ~4–11% of the global population and is associated with substantial healthcare utilization, impaired quality of life and considerable socioeconomic burden. IBS is increasingly recognized as a heterogeneous condition caused by dysregulated bidirectional communication within the gut–brain axis. Altered gastrointestinal motility, visceral hypersensitivity, epithelial barrier dysfunction, neuroimmune activation, gut microbiome and metabolome changes, central pain amplification, stress and autonomic dysregulation, and sex-related biological influences underlie pathophysiological mechanisms. IBS can develop after a gastrointestinal infection and can frequently co-occur with other disorders of gut–brain interaction, chronic pain conditions, psychological disorders and organic gastrointestinal disorders such as inflammatory bowel disease and coeliac disease. Diagnosis relies on a positive symptom-based approach using the Rome V criteria, supported by clinical assessment and limited testing to exclude differential diagnoses. Management focuses on improving symptoms and quality of life through an individualized, stepwise approach that involves patient education, dietary interventions, pharmacological therapies and gut–brain behaviour therapies. Emerging biomarkers, multi-omics approaches, digital health tools and precision medicine strategies may enable mechanism-based diagnosis and targeted treatment in the future.


  • 10 Pearls for Clinical Practice in Disorders of Gut-Brain Interaction

    by Lin Chang, Heidi M. Staudacher, Sarah Ballou, Giovanni Barbara

    Was not provided for this article.

  • Associations Between Physical Activity and Irritable Bowel Syndrome in the All of Us Research Program

    by Jack Loesch, Sarah Kim, Madison Simons, Eyad Hamza, John Brown, Sara Valencia, Samita Garg, Trisha Pasricha, Prashant Singh, Sarah Ballou, et al.

    INTRODUCTION: Irritable bowel syndrome (IBS) is a disorder of gut-brain interaction that affects over 6% of Americans. Increased physical activity improves IBS symptoms and may be associated with lower odds of IBS; however, previous studies are small or limited by self-reported measurements. This study aimed to investigate associations between Fitbit-recorded physical activity data and the prevalence of IBS. METHODS: A retrospective, cross-sectional analysis was conducted using the All of Us Research Program . Adults aged older than 18, who shared Fitbit and electronic healthcare record data, were included. Participants were placed into quartiles based on their mean daily activity metrics: steps, active minutes, sedentary minutes, and maximum heart rate. Covariates included demographics, lifestyle factors (alcohol and smoking), body mass index, education, income, and comorbidities. Multivariable logistic regression was used to analyze associations between activity metrics and IBS. RESULTS: Of 43,967 participants, 1,551 (3.5%) had an IBS diagnosis. The IBS group was 83% women, 79% White, with a median age of 53 years. Compared with the lowest quartile, participants in the highest quartile of average daily steps (odds ratio [OR]: 0.82; P = 0.028), very active minutes (OR: 0.72; P < 0.001), and maximum heart rate (OR: 0.73; P < 0.001) had significantly lower odds of IBS. Conversely, those in the highest quartile of sedentary minutes had higher odds of IBS (OR: 1.24; P = 0.007). DISCUSSION: This large, real-world study, using objective physical activity data, demonstrates that higher levels of physical activity is associated with lower odds of IBS. Prospective studies are warranted to determine whether physical activity has a causal protective effect against IBS.


  • Sexual Health and STI Counseling Is Critical but Often Overlooked in IBD

    by Alexander Goldowsky, Andrew Eidelberg, Grace Geeganage, Ajay Gade, Oriana Pando, Alessandra Saraga, Tina Deyhim, Konstantinos Papamichael, Daniel Wong, Kristen Crowell, et al.

    Background Sexual health counseling (SHC) is a critical aspect of inflammatory bowel disease (IBD) care. Less is known about sexual health counseling in patients who identify as members of a sexual or gender minority (SGM) group. Aims This study aims to characterize patient-reported sexual health counseling in SGM vs. non-SGM patients with IBD. Methods We conducted an anonymous, cross-sectional survey of patients over 18 years old with IBD, currently receiving care at a large, tertiary care IBD center. Data collection included demographics, IBD history, and patient recall of SHC. Patients who self-identified as SGM were compared to non-SGM patients, with subgroup analyses by sex assigned at birth. Means were compared using t tests and percentages compared using chi-square analysis. Results A total of 162 patients (41 SGM and 121 non-SGM) completed the survey. Both groups reported IBD impacted their sexual practices (ranging from 44% non-SGM men to 64% SGM women). SGM patients were more likely to report that their gastroenterologist asked about sexual health compared to non-SGM patients (p < .005). Importantly, 31% of respondents reported seeking SHC from their gastroenterologist (GI), placing GIs among the top sources of information regarding sexual health in this cohort. Conclusion Most study participants reported that IBD has impacted their sexual practices. SHC rates were low in all study groups despite GI providers being a primary source of information. Clearer recommendations on aspects of SHC could improve quality of care for both SGM and non-SGM patients with IBD.


  • Open Access

    Physical Health Consequences of Vicarious Trauma

    by Elisabeth Anne PhD Stelson, Glorian Sorensen, Lisa Berkman, Sarah Ballou, Dean Md Hashimoto, Laura D. Kubzansky, Erika L. ScD Sabbath

    Objective: Vicarious trauma (VT) is “secondhand” trauma healthcare workers experience when interacting with trauma survivors. The prospective relationship between workers’ VT symptoms and physical health has not been studied. Methods: Survey data from 775 hospital workers were linked to health insurance expenditures to identify stress-related conditions known as disorders of gut-brain interaction (DGBIs) occurrence within 1-year follow-up. VT symptoms (modeled continuously and categorically) and conditional odds of developing DGBI were assessed with multilevel logistic regression. Results: Conditional odds of DGBI increased 4% for every one-point increase in VT symptom score (95% confidence interval, 0.98 to 1.11; P = 0.17). Participants with high versus low VT symptoms had 3.40-times the conditional odds of DGBI (95% confidence interval, 1.44 to 8.06; P = 0.01). Conclusion: Workers with high versus low VT symptoms had significantly higher odds of developing DGBIs, indicating that VT may adversely impact workers’ physical health.


  • Rome Foundation Working Team Report on overlap in disorders of gut–brain interaction

    by Giovanni Barbara, Imran Aziz, Sarah Ballou, Lin Chang, Alexander C. Ford, Shin Fukudo, Samuel Nurko, Carolina Olano, Miguel Saps, Gregory Sayuk, et al.

    In patients with disorders of gut–brain interaction (DGBI), overlapping non-gastrointestinal conditions such as fibromyalgia, headaches, gynaecological and urological conditions, sleep disturbances and fatigue are common, as is overlap among DGBI in different regions of the gastrointestinal tract. These overlaps strongly influence patient management and outcome. Shared pathophysiology could explain this scenario, but details are not fully understood. This overlap has been shown to be of great relevance for DGBI. In addition, symptoms considered to be caused by a DGBI could have a detectable organic cause, and in patients with a diagnosed organic gastrointestinal disease, symptoms not clearly explained by the pathology defining this organic disease are common. Thus, the aims of this Rome Foundation Working Team Report were to review the literature on overlapping conditions among patients with paediatric and adult DGBI and, based on the available epidemiological and clinical evidence, make recommendations for the current diagnostic and therapeutic approach, and for future research. Specifically, we focused on other DGBI in the same or different gastrointestinal anatomical region(s), DGBI overlap with organic bowel diseases in remission, and DGBI overlap with non-gastrointestinal, non-structural conditions.


  • Open Access

    Morning Salivary Cortisol Has a Positive Correlation with GAD-7 Scores in Patients with Ulcerative Colitis

    by Cristina M. Castro, Aditya Mithal, Tina Deyhim, Loren G. Rabinowitz, Olawande Olagoke, Steven D. Freedman, Adam S. Cheifetz, Sarah K. Ballou, Konstantinos Papamichael

    Objectives: Inflammatory bowel diseases (IBDs) are chronic inflammatory conditions of the gastrointestinal tract, comprising ulcerative colitis (UC) and Crohn’s disease (CD). Earlier onset of IBD symptoms has been linked to a higher prevalence of depression and anxiety. Evidence supports that cortisol abnormalities correlate with the development and severity of autoimmune diseases. The primary aim of this study was to investigate the correlation of morning salivary cortisol levels with self-reported mood (depression and anxiety) and quality of life in patients with IBD. Methods: This was a prospective, single-center study including outpatients with IBD. Enrolled patients provided a one-time morning salivary cortisol sample and electronically completed a one-time survey encompassing self-reported quality of life (Short Inflammatory Bowel Disease Questionnaire (SIBDQ)) and mood (Patient Health Questionnaire 8 (PHQ-8), General Anxiety Disorder-7 (GAD-7)). Results: A total of 36 patients (UC, n = 21) were included in the study. There was no correlation between morning salivary cortisol and depressive symptoms (PHQ-8: r = 0.007, p = 0.968) or quality of life (SIBDQ: r = −0.095, p = 0.606). However, there was a trend towards a positive correlation between self-reported anxiety symptoms by GAD-7 and salivary cortisol (r = 0.347, p = 0.052). A subgroup analysis showed a positive correlation between morning salivary cortisol and GAD-7 scores in patients with UC (r = 0.535, p = 0.015), but not in patients with CD (r = 0.064, p = 0.843). Conclusions: This pilot study is the first to associate cortisol with anxiety symptom severity in UC. Further research is needed to investigate the link between salivary cortisol, neuropsychiatric disease, and IBD outcomes.


  • A primer for the gastroenterology provider on psychosocial assessment of patients with disorders of gut‐brain interaction

    by Sarah Ballou, Dipesh H. Vasant, Livia Guadagnoli, Bonney Reed, Giuseppe Chiarioni, Liesbeth Ten Cate, Laurie Keefer, Sarah W. Kinsinger

    Background: GI‐specific psychological factors are important contributors to patients' symptom experience and quality of life across all disorders of gut‐brain interaction (DGBI). Clinicians' ability to recognize the role of these psychological factors is essential for formulating a biopsychosocial case conceptualization and informing treatment decisions.Purpose: This article will familiarize gastroenterology providers with conceptualizing the role of GI‐specific psychological factors in DGBI and provides stepwise, practical guidance for how to assess these during clinical encounters in a time‐efficient manner.


  • Open Access

    Irritable Bowel Syndrome/Inflammatory Bowel Disease Overlap: Less Common Than We Think

    by Lauren K. Burdine, Shana Rakowsky, Laurie Grossberg, Loren Rabinowitz, Kostas Papamichael, Tina Deyhim, Chandler Yap, Adam S. Cheifetz, Sarah Ballou